Healthcare Nov 13, 2020 10:44 AM (GMT+8) · EqualOcean
Yesterday, Aikang Guobin reported and complained to China Securities Regulatory Commission, Shenzhen regulatory bureau of China Securities Regulatory Commission and China Securities Association. Xie Changyan and Zhu Hanqing, analysts of securities research team of Guoxin Securities Co., Ltd., did not comply with the basic professional code of conduct of securities analysts and issued a report that did not comply with relevant laws and regulations Research reports of listed companies required by regulations. Aikang Guobin said that Guoshen healthcare, the only subscription number operated by Guoxin Securities Economic Research Institute, released a report entitled "health in the United States: there is a reason for the big drop, exploring Ali's strategy (quick review of major events)", which makes misleading analysis and comments on the operation and development of Aikang Guobin in the main body, but it has not been confirmed that the subjective conjecture of Aikang Guobin and meinian health has not been confirmed There is the possibility of asset restructuring, which seriously deviates from the facts, misleads the majority of investors, affects the healthy secondary market share price of meinian, and has a negative impact on the normal operation of Aikang Guobin.

This text is a result of machine translation.

Related companies：